drugset / Trial / NCT00606229

A Multicenter Investigative Study of the Safety and Efficacy of Long-term Administration of Aripiprazole in Combination With Mood Stabilizer for the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode

NCT00606229

Phase 3 Completed 41 enrolled Otsuka Pharmaceutical Co., Ltd.
RandomizedSingle-groupOpen-labelTreatment

Summary

To assess the safety and efficacy of long-term administration of aripiprazole in combination with mood stabilizer (lithium or valproate) in an unblinded manner in patients with Bipolar I Disorder experiencing a manic or mixed episode

Timeline

Start
2008-01
Primary completion
2010-11
Completion
2010-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Aripiprazole Other / unclassified 24 mg Oral

Indications